- Home
- CLDI vs HCAI Comparison
CLDI vs HCAI Comparison
Compare CLDI & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- HCAI
- Stock Information
- Founded
- CLDI 2014
- HCAI 2004
- Country
- CLDI United States
- HCAI China
- Employees
- CLDI N/A
- HCAI N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- HCAI Miscellaneous manufacturing industries
- Sector
- CLDI Health Care
- HCAI Consumer Discretionary
- Exchange
- CLDI Nasdaq
- HCAI Nasdaq
- Market Cap
- CLDI 20.2M
- HCAI 21.9M
- IPO Year
- CLDI N/A
- HCAI 2025
- Fundamental
- Price
- CLDI $1.62
- HCAI $0.73
- Analyst Decision
- CLDI
- HCAI
- Analyst Count
- CLDI 0
- HCAI 0
- Target Price
- CLDI N/A
- HCAI N/A
- AVG Volume (30 Days)
- CLDI 485.8K
- HCAI 629.4K
- Earning Date
- CLDI 11-11-2025
- HCAI 01-01-0001
- Dividend Yield
- CLDI N/A
- HCAI N/A
- EPS Growth
- CLDI N/A
- HCAI N/A
- EPS
- CLDI N/A
- HCAI 0.05
- Revenue
- CLDI N/A
- HCAI $40,944,770.00
- Revenue This Year
- CLDI N/A
- HCAI N/A
- Revenue Next Year
- CLDI N/A
- HCAI N/A
- P/E Ratio
- CLDI N/A
- HCAI $14.68
- Revenue Growth
- CLDI N/A
- HCAI 19.45
- 52 Week Low
- CLDI $1.51
- HCAI $0.47
- 52 Week High
- CLDI $46.68
- HCAI $10.97
- Technical
- Relative Strength Index (RSI)
- CLDI 30.80
- HCAI N/A
- Support Level
- CLDI $1.51
- HCAI N/A
- Resistance Level
- CLDI $1.68
- HCAI N/A
- Average True Range (ATR)
- CLDI 0.12
- HCAI 0.00
- MACD
- CLDI 0.13
- HCAI 0.00
- Stochastic Oscillator
- CLDI 28.38
- HCAI 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.